Literature DB >> 23957217

Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia.

Jing Xiao1, Jianying Niu, Xianwu Ye, Qianqian Yu, Yong Gu.   

Abstract

OBJECTIVE: To identify novel potential biomarkers and evaluate combined biomarkers for diagnosing kidney injury with considerable accuracy in preeclampsia.
METHODS: The level of serum and urine neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), retinol-binding protein (RBP) and interleukin-18 (IL-18) were measured by enzyme-linked immunosorbent assay.
RESULTS: The level of serum cystatin C, urine RBP, urine NGAL and urine KIM-1 in preeclampsia group were higher than that in the normal pregnancy group. When four biomarkers are combined, the sensitivity and specificity are 100%/98.20%.
CONCLUSION: Urine KIM-1 is the most potential biomarker for renal injury in preeclampsia. The more biomarkers combined, the more sensitivity and specificity were increased.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23957217     DOI: 10.3109/10641955.2013.827203

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  8 in total

1.  Nested case-control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia.

Authors:  Yamile Lopez-Hernandez; Jorge Alejandro Saldivar-Nava; Idalia Garza-Veloz; Ivan Delgado-Enciso; Laura Elia Martinez-de-Villarreal; Patricia Yahuaca-Mendoza; Iram Pablo Rodriguez-Sanchez; Laura Lopez-Gilibets; Jorge Issac Galvan-Tejada; Carlos Eric Galvan-Tejada; Jose Maria Celaya-Padilla; Margarita L Martinez-Fierro
Journal:  Int Urol Nephrol       Date:  2016-08-29       Impact factor: 2.370

Review 2.  Why kidneys fail post-partum: a tubulocentric viewpoint.

Authors:  Patricia Villie; Marc Dommergues; Isabelle Brocheriou; Giorgina Barbara Piccoli; Jérôme Tourret; Alexandre Hertig
Journal:  J Nephrol       Date:  2018-04-10       Impact factor: 3.902

Review 3.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

4.  Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.

Authors:  Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Alicia J Jenkins; Alison J Nankervis; Kristian F Hanssen; Satish K Garg; James A Scardo; Samar M Hammad; M Kathryn Menard; Christopher E Aston; Timothy J Lyons
Journal:  Diabetes Care       Date:  2017-11-09       Impact factor: 19.112

5.  Restrictive versus Liberal Fluid Therapy for Post-Cesarean Acute Kidney Injury in Severe Preeclampsia: a Pilot Randomized Clinical Trial.

Authors:  Wallace Andrino da Silva; Carlo Victor A Varela; Aline Macedo Pinheiro; Paula Castro Scherer; Rossana P V Francisco; Marcelo Luis Abramides Torres; Maria José C Carmona; Fernando Bliacheriene; Lúcia C Andrade; Paolo Pelosi; Luiz Marcelo S Malbouisson
Journal:  Clinics (Sao Paulo)       Date:  2020-07-22       Impact factor: 2.365

6.  Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD.

Authors:  Kate Wiles; Kate Bramham; Paul T Seed; Lesia O Kurlak; Hiten D Mistry; Catherine Nelson-Piercy; Liz Lightstone; Lucy C Chappell
Journal:  Kidney Int Rep       Date:  2019-03-26

Review 7.  The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.

Authors:  Krzysztof Ratajczyk; Andrzej Konieczny; Adrian Czekaj; Paweł Piotrów; Marek Fiutowski; Kornelia Krakowska; Paweł Kowal; Wojciech Witkiewicz; Karolina Marek-Bukowiec
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

8.  Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.

Authors:  Hongqi Ren; Xuan Zhou; Deshu Dai; Xiang Liu; Liangxi Wang; Yifang Zhou; Xiaomei Luo; Qing Cai
Journal:  BMC Nephrol       Date:  2015-08-18       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.